INSMED INC (INSM) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $74.56M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $74.56M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $74.56M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 1.35B USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Amounts owed to suppliers | 74.56M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Deferred Revenue, Current |
| Deferred revenue due within one year | (m) | Deferred Revenue, Current |
| Deferred revenue due after one year | (m) | Deferred Revenue, Current |
| Reported other obligations due within one year | (m) | Other Liabilities, Current |
| Reported other noncurrent obligations | 5.87M USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Deferred Revenue, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $13.93M |
| Finance lease obligations | $22.44M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $74.56M | (m) | (m) | (m) | $1.35B | (m) | (m) | (m) | $5.87M | (m) |
| 2026-03-31 | (m) | $73.38M | (m) | (m) | (m) | $1.37B | (m) | (m) | (m) | $5.68M | (m) |
| 2025-12-31 | (m) | $79.91M | (m) | (m) | (m) | $1.53B | (m) | (m) | (m) | $5.65M | (m) |
| 2025-09-30 | (m) | $79.59M | (m) | (m) | (m) | $1.42B | (m) | (m) | (m) | $5.59M | (m) |
| 2025-06-30 | (m) | $74.05M | (m) | (m) | (m) | $1.23B | (m) | (m) | (m) | $5.56M | (m) |
| 2025-03-31 | (m) | $57.68M | (m) | (m) | (m) | $1.70B | (m) | (m) | (m) | $5.12M | (m) |
| 2024-12-31 | (m) | $73.03M | (m) | (m) | (m) | $1.74B | (m) | (m) | (m) | $499.00K | (m) |
| 2024-09-30 | (m) | $64.95M | (m) | (m) | (m) | $1.57B | (m) | (m) | (m) | $3.36M | (m) |
| 2024-06-30 | (m) | $51.36M | (m) | (m) | (m) | $1.77B | (m) | (m) | (m) | $3.19M | (m) |
| 2024-03-31 | (m) | $44.02M | (m) | (m) | (m) | $1.62B | (m) | (m) | (m) | $3.17M | (m) |
| 2023-12-31 | (m) | $65.39M | (m) | (m) | (m) | $1.66B | (m) | (m) | (m) | $3.15M | (m) |
| 2023-09-30 | (m) | $65.38M | (m) | (m) | (m) | $1.61B | (m) | (m) | (m) | $5.92M | (m) |
| 2023-06-30 | (m) | $55.70M | (m) | (m) | (m) | $1.59B | (m) | (m) | (m) | $11.16M | (m) |
| 2023-03-31 | (m) | $56.67M | (m) | (m) | (m) | $1.56B | (m) | (m) | (m) | $9.88M | (m) |
| 2022-12-31 | (m) | $50.46M | (m) | (m) | (m) | $1.57B | (m) | (m) | (m) | $9.39M | (m) |
| 2022-09-30 | (m) | $11.58M | (m) | (m) | (m) | $1.02B | (m) | (m) | (m) | $11.34M | (m) |
| 2022-06-30 | (m) | $31.14M | (m) | (m) | (m) | $1.01B | (m) | (m) | (m) | $14.38M | (m) |
| 2022-03-31 | (m) | $48.57M | (m) | (m) | (m) | $1.03B | (m) | (m) | (m) | $15.53M | (m) |
| 2021-12-31 | (m) | $35.78M | (m) | (m) | (m) | $833.04M | (m) | (m) | (m) | $20.07M | (m) |
| 2021-09-30 | (m) | $23.53M | (m) | (m) | (m) | $806.93M | (m) | (m) | (m) | $23.88M | (m) |
| 2021-06-30 | (m) | $31.08M | (m) | (m) | (m) | $698.73M | (m) | (m) | (m) | $12.81M | (m) |
| 2021-03-31 | (m) | $22.42M | (m) | (m) | (m) | $490.75M | (m) | (m) | (m) | $9.30M | (m) |
| 2020-12-31 | (m) | $42.85M | (m) | $0.00 | (m) | $520.27M | (m) | (m) | (m) | $9.18M | (m) |
| 2020-09-30 | (m) | $22.15M | (m) | $0.00 | (m) | $483.65M | (m) | (m) | (m) | $10.42M | (m) |
| 2020-06-30 | (m) | $25.00M | (m) | $0.00 | (m) | $480.05M | (m) | (m) | (m) | $11.34M | (m) |
| 2020-03-31 | (m) | $18.19M | (m) | $78.00K | (m) | $469.82M | (m) | (m) | (m) | $10.96M | (m) |
| 2019-12-31 | (m) | $13.18M | (m) | $280.00K | (m) | $480.63M | (m) | (m) | (m) | $10.61M | (m) |
| 2019-09-30 | (m) | $20.41M | (m) | $130.00K | (m) | $459.08M | (m) | (m) | (m) | $11.26M | (m) |
| 2019-06-30 | (m) | $17.03M | (m) | $234.00K | (m) | $446.21M | (m) | (m) | (m) | $522.00K | (m) |
| 2019-03-31 | (m) | $30.22M | (m) | $82.00K | (m) | $451.78M | (m) | (m) | (m) | $504.00K | (m) |
| 2018-12-31 | (m) | $17.74M | (m) | $1.53M | (m) | $396.29M | (m) | (m) | (m) | $0.00 | (m) |
| 2018-09-30 | (m) | $16.58M | (m) | $472.00K | (m) | $370.11M | (m) | (m) | (m) | $826.00K | (m) |
| 2018-06-30 | (m) | $15.97M | (m) | $630.00K | (m) | $353.60M | (m) | (m) | (m) | $805.00K | (m) |
| 2018-03-31 | (m) | $13.18M | (m) | $556.00K | (m) | $338.30M | (m) | (m) | (m) | $785.00K | (m) |
| 2017-12-31 | (m) | $14.67M | (m) | $646.00K | (m) | $100.99M | (m) | (m) | (m) | $765.00K | (m) |
| 2017-09-30 | (m) | $9.35M | (m) | $616.00K | (m) | $84.90M | (m) | (m) | (m) | $747.00K | (m) |
| 2017-06-30 | (m) | $11.03M | (m) | $694.00K | (m) | $82.19M | (m) | (m) | (m) | $729.00K | (m) |
| 2017-03-31 | (m) | $8.45M | (m) | $674.00K | (m) | $78.97M | (m) | (m) | (m) | $711.00K | (m) |
| 2016-12-31 | (m) | $10.44M | (m) | $728.00K | (m) | $83.47M | (m) | (m) | (m) | $693.00K | (m) |
| 2016-09-30 | (m) | $8.28M | (m) | $647.00K | (m) | $58.81M | (m) | (m) | (m) | $676.00K | (m) |
| 2016-06-30 | (m) | $9.40M | (m) | $716.00K | (m) | $49.12M | (m) | (m) | (m) | $660.00K | (m) |
| 2016-03-31 | (m) | $8.69M | (m) | $686.00K | (m) | $45.24M | (m) | (m) | (m) | $586.00K | (m) |
| 2015-12-31 | (m) | $7.47M | (m) | $683.00K | (m) | $44.86M | (m) | (m) | (m) | $572.00K | (m) |
| 2015-09-30 | (m) | $10.86M | (m) | $682.00K | (m) | $46.74M | (m) | (m) | (m) | $44.00K | (m) |
| 2015-06-30 | (m) | $8.68M | (m) | $701.00K | (m) | $43.17M | (m) | (m) | (m) | $102.00K | (m) |
| 2015-03-31 | (m) | $7.86M | (m) | $716.00K | (m) | $41.29M | (m) | (m) | (m) | $162.00K | (m) |
| 2014-12-31 | (m) | $9.25M | (m) | (m) | (m) | $44.63M | (m) | (m) | (m) | $23.00K | (m) |
| 2014-09-30 | (m) | $8.87M | (m) | (m) | (m) | $36.18M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $11.41M | (m) | (m) | (m) | $38.56M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $9.82M | (m) | (m) | (m) | $34.88M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $5.93M | (m) | (m) | (m) | $33.17M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | $4.66M | (m) | (m) | (m) | $32.83M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $7.87M | (m) | (m) | (m) | $33.54M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $8.18M | (m) | (m) | (m) | $35.41M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $7.06M | (m) | (m) | (m) | $32.68M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | $2.98M | (m) | (m) | (m) | $15.85M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $3.20M | (m) | (m) | (m) | $16.34M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $2.88M | (m) | (m) | (m) | $5.12M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $2.33M | (m) | (m) | (m) | $5.57M | (m) | $0.00 | (m) | (m) | (m) |
| 2011-09-30 | (m) | $1.50M | (m) | (m) | (m) | $3.73M | (m) | $421.00K | (m) | (m) | (m) |
| 2011-06-30 | (m) | $1.92M | (m) | (m) | (m) | $3.55M | (m) | $195.00K | (m) | (m) | (m) |
| 2010-12-31 | (m) | $1.45M | (m) | (m) | (m) | $3.42M | (m) | $402.00K | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |